OXFORD, Miss., Dec. 21, 2006 (PRIME NEWSWIRE) -- Modern Technology Corp (Pink Sheets:MODC), a diversified technology development and acquisition company, announced today Peter Duesberg, PhD has been invited to become a Honorary Member of the World Innovation Foundation. (www.thewif.org.uk).
Anthony Welch, Chairman, said: "We applaud Peter Duesberg's invitation to this outstanding organization. His example of excellence, integrity, and rigorous science provides inspiration and leadership to us all. We feel this to be a further validation of his decades of outstanding scientific work. Insight Medical Group is exceptionally fortunate to have him as its lead scientific advisor. Without his cancer research work, the AnuCyte system may never have seen the light of day."
About the AnuCyte Cancer Detection System
The AnuCyte system is an automated cancer detection system that can quickly detect any form of tissue-based cancer. The system rapidly and accurately identifies cancer at any stage in its development and also identifies healthy cancer-free cells in the same test. The system eliminates heretofore unreliable, subjective, and error-prone pathology diagnosis of cancer and delivers an automated and objective measurement of the presence or absence of cancer. The AnuCyte system is the first and only system in the world that uses the measurement of advanced chromosomal imbalance as the primary or sole means of detecting cancer.
The inventor of the AnuCyte system, Dr. David Rasnick, PhD and his scientific research collaborator, Dr. Peter Duesberg, PhD, have been prominent names internationally for many years for their research and publications. Investors may wish to read a recent article in Newsweek concerning the cancer research of Dr. Duesberg:
http://www.msnbc.msn.com/id/14757547/site/newsweek/
About Insight Medical Group
Insight Medical Group is a specialized biosciences development company whose mission is to bring world-changing medical technology and research to market in the areas of cancer and AIDS. The AnuCyte Cancer Detection System was invented by Dr. David Rasnick, PhD. The technology behind AnuCyte and the chromosomal imbalance theory is the result of 45 years of combined cancer research by Dr. David Rasnick, PhD and Dr. Peter Duesberg, PhD, who continues his studies on cancer research at the University of California, Berkeley.
About Modern Technology Corp
Modern Technology Corp, a diversified technology development and acquisition company, builds revenues through continuous growth, strategic acquisitions, and commercialization of nascent technology. MODC improves operating efficiencies through the elimination of cost redundancies and realized synergy between subsidiaries. MODC is a fully-reporting public company with the US Securities and Exchange Commission. For more information on the company's SEC filings, visit www.sec.gov. The company's web address is: http://www.moderntechnologycorp.com
Safe-Harbor Statement
This press release contains statements (such as projections regarding future performance) that are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those projected as a result of certain risks and uncertainties, including but not limited to those detailed from time to time in the Company's filings with the Securities and Exchange Commission.